BRIANNE DIFALCO: Open Payments
NPI 1194470930 · HILLSBORO, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$267 in 12 payments from 8 companies in 2025. Trend: 2023 $21 · 2024 $318 · 2025 $267
Food & beverage: $267
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 2 | $57 |
| Otsuka America Pharmaceutical, Inc. | 2 | $43 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $41 |
| Gilead Sciences, Inc. | 2 | $38 |
| Teva Pharmaceuticals USA, Inc. | 1 | $24 |
| Corcept Therapeutics | 1 | $24 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $22 |
| Exact Sciences Corporation | 1 | $17 |
Products named: VRAYLAR, CAPLYTA, ABILIFY ASIMTUFII, AUSTEDO XR, Korlym, XIFAXAN, The Cologuard Plus Collection Kit, REXULTI.
Industry payments across OR — which companies pay providers there.
